INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,579,625 | +22.4% | 1,290,282 | +2.3% | 0.02% | +27.8% |
| Q2 2023 | $26,609,089 | +24.5% | 1,261,095 | +0.6% | 0.02% | +20.0% |
| Q1 2023 | $21,364,196 | -17.8% | 1,253,032 | -3.7% | 0.02% | -25.0% |
| Q4 2022 | $25,984,569 | -9.1% | 1,300,529 | -2.0% | 0.02% | -13.0% |
| Q3 2022 | $28,582,000 | +38.7% | 1,326,945 | +27.0% | 0.02% | +53.3% |
| Q2 2022 | $20,602,000 | +9.3% | 1,044,748 | +30.2% | 0.02% | +25.0% |
| Q1 2022 | $18,850,000 | -11.6% | 802,136 | +2.5% | 0.01% | -7.7% |
| Q4 2021 | $21,318,000 | +2.2% | 782,603 | +3.3% | 0.01% | -7.1% |
| Q3 2021 | $20,861,000 | +1.6% | 757,514 | +4.9% | 0.01% | +7.7% |
| Q2 2021 | $20,542,000 | +8.4% | 721,792 | +29.7% | 0.01% | 0.0% |
| Q1 2021 | $18,958,000 | +12.3% | 556,579 | +9.8% | 0.01% | +8.3% |
| Q4 2020 | $16,876,000 | -2.2% | 506,964 | -5.6% | 0.01% | -20.0% |
| Q3 2020 | $17,257,000 | +18.3% | 536,941 | +1.4% | 0.02% | +15.4% |
| Q2 2020 | $14,584,000 | +186.2% | 529,554 | +66.6% | 0.01% | +116.7% |
| Q1 2020 | $5,095,000 | -2.1% | 317,827 | +45.9% | 0.01% | +50.0% |
| Q4 2019 | $5,203,000 | +35.9% | 217,844 | +0.4% | 0.00% | +33.3% |
| Q3 2019 | $3,829,000 | -35.1% | 217,079 | -5.8% | 0.00% | -40.0% |
| Q2 2019 | $5,901,000 | +1.8% | 230,512 | +15.6% | 0.01% | 0.0% |
| Q1 2019 | $5,799,000 | +207.6% | 199,476 | +38.9% | 0.01% | +150.0% |
| Q4 2018 | $1,885,000 | -37.4% | 143,646 | -3.5% | 0.00% | -33.3% |
| Q3 2018 | $3,010,000 | -14.7% | 148,867 | -0.3% | 0.00% | 0.0% |
| Q2 2018 | $3,530,000 | +0.7% | 149,274 | -4.1% | 0.00% | 0.0% |
| Q1 2018 | $3,505,000 | -28.1% | 155,661 | -0.5% | 0.00% | -25.0% |
| Q4 2017 | $4,877,000 | -22.7% | 156,420 | -22.6% | 0.00% | -33.3% |
| Q3 2017 | $6,309,000 | +81.6% | 202,131 | -0.2% | 0.01% | +100.0% |
| Q2 2017 | $3,474,000 | -2.0% | 202,443 | -0.0% | 0.00% | -25.0% |
| Q1 2017 | $3,545,000 | +27.2% | 202,451 | -3.9% | 0.00% | 0.0% |
| Q4 2016 | $2,787,000 | -8.3% | 210,665 | +0.6% | 0.00% | 0.0% |
| Q3 2016 | $3,039,000 | +48.6% | 209,328 | +0.9% | 0.00% | +33.3% |
| Q2 2016 | $2,045,000 | -24.0% | 207,373 | -2.4% | 0.00% | -25.0% |
| Q1 2016 | $2,691,000 | -30.1% | 212,398 | +0.1% | 0.00% | -33.3% |
| Q4 2015 | $3,851,000 | +2.3% | 212,162 | +4.7% | 0.01% | 0.0% |
| Q3 2015 | $3,764,000 | -22.0% | 202,705 | +2.5% | 0.01% | -14.3% |
| Q2 2015 | $4,827,000 | +34.0% | 197,672 | +14.2% | 0.01% | +40.0% |
| Q1 2015 | $3,601,000 | +34.5% | 173,100 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $2,678,000 | +20.7% | 173,100 | +1.8% | 0.00% | 0.0% |
| Q3 2014 | $2,219,000 | -31.7% | 170,000 | +4.6% | 0.00% | -20.0% |
| Q2 2014 | $3,247,000 | -10.3% | 162,500 | -14.5% | 0.01% | -16.7% |
| Q1 2014 | $3,618,000 | +23.3% | 190,034 | +10.2% | 0.01% | +20.0% |
| Q4 2013 | $2,934,000 | -1.1% | 172,500 | -9.2% | 0.01% | -16.7% |
| Q3 2013 | $2,966,000 | +60.3% | 190,000 | +22.8% | 0.01% | +50.0% |
| Q2 2013 | $1,850,000 | – | 154,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |